688488 艾迪药业
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)1.576-13.407-6.545-9.893-2.246
总资产报酬率 ROA (%)0.828-7.810-4.472-8.032-2.081
投入资产回报率 ROIC (%)1.023-9.201-5.052-8.871-2.198

边际利润分析
销售毛利率 (%)62.03654.93346.19542.90133.191
营业利润率 (%)16.086-39.364-22.376-58.175-17.143
息税前利润/营业总收入 (%)17.740-36.632-19.843-58.139-17.375
净利润/营业总收入 (%)12.943-33.230-18.492-50.812-11.726

收益指标分析
经营活动净收益/利润总额(%)61.53078.84396.92891.603123.454
价值变动净收益/利润总额(%)28.634-10.678-15.376-11.805-19.142
营业外收支净额/利润总额(%)-0.8460.9230.0400.218-3.697

偿债能力分析
流动比率 (X)1.4051.3791.7752.4198.936
速动比率 (X)0.9920.9861.3991.9497.701
资产负债率 (%)42.35342.92335.55727.5788.700
带息债务/全部投入资本 (%)30.82531.14023.71913.326-0.187
股东权益/带息债务 (%)211.166207.807305.446617.002-52,227.997
股东权益/负债合计 (%)124.135122.234181.238262.6081,049.375
利息保障倍数 (X)9.918-11.822-7.805-356.43520.612

营运能力分析
应收账款周转天数 (天)60.608138.534129.628126.837126.673
存货周转天数 (天)315.545420.481277.339349.064213.182